Sorafenib for advanced hepatocellular carcinoma: A systematic review

Acta Academiae Medicinae Sinicae

Volumn 33, Issue 1, 2011, Pages 51-57

  Zou, Ling Lin ^a,b   Ma, Li ^a   Tian, Jin Hui ^b   Yang, Ke Hu ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b LANZHOU UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; Meta analysis; Sorafenib; Systematic review

Indexed keywords

PLACEBO; SORAFENIB;

ARTICLE; CANCER GROWTH; COCHRANE LIBRARY; DATA BASE; DISEASE CONTROL; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EMBASE; GASTROINTESTINAL TOXICITY; HUMAN; LIVER CELL CARCINOMA; MEDLINE; OVERALL SURVIVAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN TOXICITY; SYSTEMATIC REVIEW;

ANTINEOPLASTIC AGENTS; BENZENESULFONATES; CARCINOMA, HEPATOCELLULAR; HUMANS; LIVER NEOPLASMS; PYRIDINES;

EID: 79953802639     PISSN: 1000503X     EISSN: None     Source Type: Journal    
DOI: 10.3881/j.issn.1000-503X.2011.01.011     Document Type: Article

References (8)

1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics 2002 [J]. CA Cancer J Clin, 2005, 55(2):74-108.
2. Llovet JM, Schwartz M, Mazzaferro V, et al. Resection and liver transplantation for hepatocellular carcinoma [J]. Semin Liver Dis, 2005, 25(2):181-200. (Pubitemid 40781071)
3. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma [J]. N Engl J Med, 2008, 359(4):378-390.
4. Higgins JPT, Green S. The Cochrane Collaboration. Cochrane Handbook for Systematic Reviews of Interventions Version 5.0.2 [EB/OL]. [2009-9-20]. http://www.cochrane-handbook.org
5. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial [J]. Lancet Oncol, 2009, 10(1):25-34.
6. Wu SH, Chen JJ, Andrzej K, et al. Incidence and risk of hypertension with sorafenib in patients with cancer: a systematic review and meta-analysis [J]. Lancet Oncol, 2008, 9(2):117-123.
7. Melman A, Grim CE, Weinberger MH, et al. Increased incidence of renal cell carcinoma with hypertension [J]. J Urol, 1977, 118(4):531-532. (Pubitemid 8227389)